Cargando…
Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby
VISTA is an up-and-coming immune checkpoint molecule that can become the target of new cancer immunotherapy treatments. Immune cells in the tumor microenvironment can largely influence the progression of cancer through inhibitory and stimulatory pathways. Indeed, VISTA is expressed on many immune ce...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085549/ https://www.ncbi.nlm.nih.gov/pubmed/33937071 http://dx.doi.org/10.3389/fonc.2021.658488 |